跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BUPRADONE 2/0.5 buprenorphine (as hydrochloride) 2 mg and naloxone (as hydrochloride dihydrate) 0.5 mg sublingual tablet - TGA Drug Approval Details
Approvals
/
TGA
/
BUPRADONE 2/0.5 buprenorphine (as hydrochloride) 2 mg and naloxone (as hydrochloride dihydrate) 0.5 mg sublingual tablet
Approved
STANDARD
BUPRADONE 2/0.5 buprenorphine (as hydrochloride) 2 mg and naloxone (as hydrochloride dihydrate) 0.5 mg sublingual tablet
Indivior Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
17d02e724506c4e1
Company
Indivior Pty Ltd
Type
Standard
Approval Details
Approval Id
17d02e724506c4e1
Product Name
BUPRADONE 2/0.5 buprenorphine (as hydrochloride) 2 mg and naloxone (as hydrochloride dihydrate) 0.5 mg sublingual tablet
Artg Id
152483
Artg Name
BUPRADONE 2/0.5 buprenorphine (as hydrochloride) 2 mg and naloxone (as hydrochloride dihydrate) 0.5 mg sublingual tablet
Sponsor
Indivior Pty Ltd
Company Detail Path
/organization/indivior-pty-ltd
Artg Date
2008-09-09
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
17d02e724506c4e1
Type
Standard
Back to TGA Approvals